Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
SUPN similar filings
- 14 Sep 20 Supernus Submits NDA for SPN-830 for Continuous Treatment of ON-OFF Episodes in Adults with Parkinson’s Disease Who Have Failed Two Treatments
- 9 Sep 20 Supernus to Present at the Morgan Stanley 18th Annual Global Healthcare Conference
- 2 Sep 20 Supernus to Present at the Wells Fargo Virtual Health Care Conference
- 24 Aug 20 Financial Statements and Exhibits
- 19 Aug 20 Supernus Announces Second Quarter 2020 Financial Results
- 11 Aug 20 Supernus Announces Preliminary Second Quarter 2020 Revenue
- 29 Jun 20 Supernus Sues Apotex for Infringement of Oxtellar XR® Patents
Filing view
External links
Exhibit 23.1 Consent of Independent Auditors We agree to the inclusion in this Current Report on Form 8-K/A of Supernus Pharmaceuticals, Inc. of our report, dated March 30, 2020, on our audit of the consolidated financial statements of USWM Enterprises, LLC and Subsidiaries for the years ended December 31, 2019 and 2018. Louisville, Kentucky August 24, 2020 Lexington ■ Louisville ■ Raleigh deandorton.com